IQVIA HOLDINGS INC.

(IQV)
  Report
Delayed Nyse  -  05/20 04:04:30 pm EDT
201.83 USD   +0.04%
05/05TikoMed AB and IQVIA Announce Strategic Collaboration for the Development of TikoMed's Lead Drug Platform Candidate ILB®
CI
05/04TRANSCRIPT : IQVIA Holdings Inc. - Special Call
CI
04/29IQVIA Holdings Shares Rise Midday Following Piper Upgrade, Target Increase
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

IQVIA : OneKey Powers Precision Targeting

12/11/2021 | 08:26pm EDT

Which physicians are prospects for practice transitions? OneKey data supported a consulting company with national reach, as it helps traditional medical practices transition to concierge medicine and personalized care models. Read this case study to learn how.

Disclaimer

IQVIA Holdings Inc. published this content on 10 December 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 12 December 2021 01:25:02 UTC.


© Publicnow 2021
All news about IQVIA HOLDINGS INC.
05/05TikoMed AB and IQVIA Announce Strategic Collaboration for the Development of TikoMed's ..
CI
05/04TRANSCRIPT : IQVIA Holdings Inc. - Special Call
CI
04/29IQVIA Holdings Shares Rise Midday Following Piper Upgrade, Target Increase
MT
04/29Piper Sandler Lifts IQVIA Holdings to Overweight From Neutral, Price Target to $255 Fro..
MT
04/28IQVIA HOLDINGS INC. Management's Discussion and Analysis of Financial Condition and Re..
AQ
04/28Tranche Update on IQVIA Holdings Inc.'s Equity Buyback Plan announced on October 31, 20..
CI
04/28Stifel Nicolaus Adjusts Price Target for IQVIA Holdings to $271 From $297, Maintains Bu..
MT
04/28KeyBanc Adjusts IQVIA Holdings' Price Target to $250 from $290, Keeps Overweight Rating
MT
04/28IQVIA HOLDINGS INC. : SEC Filing 10Q-1
CO
04/28IQVIA HOLDINGS INC. : SEC Filing 10Q-1
CO
More news
Analyst Recommendations on IQVIA HOLDINGS INC.
More recommendations
Financials (USD)
Sales 2022 14 632 M - -
Net income 2022 1 291 M - -
Net Debt 2022 10 188 M - -
P/E ratio 2022 30,2x
Yield 2022 -
Capitalization 38 202 M 38 202 M -
EV / Sales 2022 3,31x
EV / Sales 2023 2,95x
Nbr of Employees 82 000
Free-Float 73,3%
Chart IQVIA HOLDINGS INC.
Duration : Period :
Iqvia Holdings Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends IQVIA HOLDINGS INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 18
Last Close Price 201,83 $
Average target price 266,94 $
Spread / Average Target 32,3%
EPS Revisions
Managers and Directors
Ari Bousbib Chairman, President & Chief Executive Officer
Ronald Earl Bruehlman Chief Financial Officer & Executive Vice President
Karl Guenault Chief Information Officer & Senior Vice President
Jeffrey A. Spaeder Chief Medical & Scientific Officer
Costa Panagos President-Research & Development Solutions
Sector and Competitors
1st jan.Capi. (M$)
IQVIA HOLDINGS INC.-28.46%38 202
MODERNA, INC.-46.35%54 195
LONZA GROUP AG-27.84%41 796
SEAGEN INC.-9.68%25 704
ICON PUBLIC LIMITED COMPANY-30.22%17 567
ALNYLAM PHARMACEUTICALS, INC.-23.72%15 980